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Introduction
Basal ganglia dysfunction leads to the lack of automatic execution of learned motor sequences (Marsden, 1982) and to the development of Parkinsonian motor symptoms (Lee et al., 1994) , including changes in gait and speech.
Gait disorders in PD (Hoehn and Yahr, 1967) , constitute one of the main factors affecting patients' independence and quality of life (Koplas et al., 1999) . PP walk slower, with shorter step length and a compensatory increased walking cadence (Blin et Approximately 70% of PP experience speech difficulties attributed to bradykinetic and hypokinetic articulatory movements, orofacial hypomimy, rigidity and rest tremor (Hartelius and Svensson, 1994) .
PPs' speech timing deficits seem to have some points in common with their spatiotemporal gait deficits. Speech velocity often decreases in PP (Canter, 1963; Metter and Hanson, 1986) just like walking velocity. The interpauses speech duration (ISD) is usually shortened in PP (Forrest et al., 1989; Hammen and Yorkston, 1996) , in line with the step length.
PP are subject to dysprosody, and show less variability in the fundamental frequency and intensity and more speech velocity and pausing abnormalities than control subjects (CS) (Canter, 1963; Harel et al., 2004; Kegl et al., 1999) . Dysfluent behavior has also been described in PP (Benke et al., 2000) , consisting mainly of repetitive speech phenomena involving the repetition of syllables, words or phrases. Skodda and Schlegel (2008) reported that during a standardized reading task, the speech velocity of PP accelerates more strongly while speaking and the total number of pauses decreases significantly, which indicates that their speech rhythm and timing organization processes are impaired. Physicians often have the feeling that paroxystic speech velocity accelerations develop in line with gait festinations and dysrhythmic pauses and that repetitive speech phenomenon such as stuttering, iterations and palilalia are somewhat comparable to freezing of gait. Few studies have focused on the effects of levodopa on speech timing parameters. Levodopa does not improve speech velocity (Wolfe et al., 1975) Our aim was to compare gait and speech patterns of PP and CS, and to analyse the patients' responses to levodopa and STN-DBS. Another aim was to determine whether there exist any correlations between the spatiotemporal gait and temporal speech parameters with a view to establishing whether, in line with what occurs with gait, hypokinesia may be mainly responsible for these patients' speech timing disorders and whether accelerated timing strategies may be used as compensatory mechanisms.
II. MATERIAL AND METHODS

Subjects
Eleven PP, 7 males and 4 females (mean age 64.5) and 11 age-matched CS, 7 males and 4 females (mean age 66.3) with no neurological history took part in these experiments after giving their informed consent. The project was approved by the local ethical committee.
All the PP had undergone bilateral STN-DBS and were stable when the study was conducted.
PP and controls with any other disorder possibly affecting their walking or speaking abilities were excluded from the study.
PPs' level of functional disability was determined on the Unified Parkinson's Disease Rating Scale (UPDRS) motor and axial scores in four treatment conditions (OFF and ON states of STN-DBS and levodopa). The patients' characteristics are given in Table 1 .
Test procedure
Gait and speech recordings were conducted in the four treatment conditions, always in the same order. Gait recordings were run always just before speech recordings. 3. the PP were tested in the ON STN-DBS state at least 12 hours after undergoing STN-DBS treatment and in the OFF levodopa state at least 12 hours after taking their last DT dose (ON/OFF).
4. the PP were tested in the OFF STN-DBS state at least 3 hours after undergoing STN-DBS treatment and in the ON levodopa state at the peak effect of a suprathreshold dose of levodopa (OFF/ON).
The gait and speech recordings were conducted just once on the CS.
Gait recordings
Tasks
Subjects were instructed to walk on level ground at their natural speed (NS), slowest as compared with the first task (SS) and as fast as possible without running (FS).
Experimental recordings
Kinematic analysis was performed with the ELITE TV image processing system (Ferrigno and Pedotti, 1985) . 22 reflective markers 1 cm in diameter were taped onto the subjects' skin at specific symmetrical anatomical points. The recordings were taken with 6 TV cameras at a sampling rate of 100 Hz.
Gait parameters
Based on the kinematic recording, temporal and spatial gait parameters were measured during each trial: walking velocity (m/s), step length (mm) and walking cadence (step/min).
Speech recordings
Tasks
Subjects had to read a short printed text at their natural speed (NS), slowest as compared with the natural condition (SS) and as fast as possible (FS).
Experimental recordings
Subjects were seated in a quiet room. Temporal acoustic recordings obtained via a headphone were analyzed using the Prosody R software program, which is part of the Software Environment for Speech Analysis and Evaluation (SESANE R ).
Speech parameters
Based on the acoustic data the following parameters were measured at each trial:
-Speech velocity (syllables/second) -Interpause speech duration (ISD in seconds): It corresponds to the time interval between two pauses. It was determined by tallying the duration occurring between two pauses.
-Speech Index of Rhythmicity (SPIR): this is an index to evaluate speech rhythmicity in the same way as the walking cadence. As the alternation between pauses and speech gives rhythm to speech just as the alternation between steps and double foot support phases gives rhythm to gait, SPIR corresponds the number of speech interpauses per minute.
Statistical procedure
Because of the small size and the non normal distribution of our samples, all the tests applied were non parametric tests. For each subject and condition, all variables have been averaged over the three trials. In the OFF/OFF situation, two PP were unable to walk.
Nevertheless, we have used the data of these patients in the other conditions of treatment. The statistics given are medians and interquartiles.
Differences between CS and PP were tested with a Mann-Whitney U test. The task effect in each group and the treatment effect in the PP group were analyzed with a Friedman ANOVA. In order to isolate statistical differences when the hypothesis of differences was verified we have realised a multiple comparison procedures (post-hoc tests) using a Student-Newman-Keuls (SNK) test. The correlations between gait and speech parameters were tested with a Spearman test.
RESULTS
Gait analysis 1.1 Effects of PD
In order to assess the effects of PD on gait parameters, the gait characteristics of PP in the OFF/OFF state of treatment were compared with those of the CS.
Whatever experimental situations, gait velocity of PP was slower than that of CS (T ( and T(1.18)=59, p<0.01 in conditions NS, SS and FS, respectively); whatever the experimental task the cadence was similar in both groups.
Effects of treatment
The gait characteristics of PP in each mode of treatment are given in figure 1.
a. Walking Velocity
The statistical analysis revealed a global effect of the treatment on walking velocity in all experimental condition (chi²=9.41, p<0.01; chi²=17.93, p<0.001 and chi²=15, p<0.01 for NS, SS, and FS respectively). Walking velocity increased similarly with levodopa, DBS and combination of both compared with the complete OFF state.
b.
Step Length
In the NS condition, we showed a significant global effect of treatment on step length In the NS task, ISDs' values were similar in both groups. In the SS task, ISD's value of PP was significantly longer than that of CS (T=160.5, p<0.05); whereas in the FS task, the ISD of PP was significantly shorter than that of CS (T=91, p<0.05).
In NS and FS tasks, the SPIR did not differ significantly between the two groups. In the SS task, the SPIR values of PP were significantly lower than those of CS (T=93, p<0.05).
Effects of treatment
In order to assess the effects of treatment, speech performances of PP were compared depending on the treatment undergone. The speech performances of PP are given in figure 3.
a. Speech velocity
Whatever the experimental condition, no significant differences were observed between the four states of treatment. 
DISCUSSION:
Our results demonstrate large similarities between the gait's pattern and speech's involvement in PD and in their responses to STN-DBS and levodopa treatment
Gait and speech impairments in PD
The spatiotemporal gait disorders observed in PD are in line with those previously Few data are available to compare our results, Canter (1963) and Metter and Hanson (1986) observed changing speech velocities in PP. The ISD has often been reported to be shorter in PP than in CS during both reading and spontaneous speech (Forrest et al., 1989; Hammen and Yorkston, 1996) . The speech velocity also changes with the co-existence of bradylalia and tachylalia (Gentil et al., 1995) . The present results show in addition that the speech velocity of PP without treatment did not differ between SS and NS, and that their ISD remained unchanged under all the experimental conditions. In line with the changes observed in their walking patterns, PP therefore have some difficulty in modulating their speech velocities because they are no longer able to internally control the ISD. However, the internal speech rhythm regulation processes seem to be also impaired, since the SPIR remained unchanged at NS and FS condition.
Effect of levodopa and STN-DBS on gait and speech deficits
As regards the patients' responses to treatment, their walking velocities were greatly improved by both STN-DBS and levodopa, probably due to an increase in the step length, whereas the walking cadence remained unchanged in NS and FS. In all tasks, no significant difference between STN-DBS and levodopa was observed, but a cumulative effect was which is a rhythmic parameter, is probably regulated by a non dopaminergic structure.
Levodopa and STN-DBS had no effect on the patients' speech velocity but increased the ISD. Combined treatment restored the patients' ability to modulate their ISD. The ISD therefore seems to be the main clinical manifestation of speech akinesia, since this parameter is regulated by the dopaminergic basal ganglia loop. The effects of treatment on the SPIR were often not significant. This finding probably means that in the case of both speech and gait, the rhythm is regulated by a non dopaminergic structure.
Gait and speech deficits in PD: a common feature?
This is the first time that correlations have been made between gait and speech parameters in PD. In CS and PP undergoing no treatment or under STN-DBS treatment alone, a significant correlation was found between walking velocity and speech velocity. In other words, CS and PP who walk faster also speak faster. This outcome seems to be modified by levodopa.
A significant positive correlation between step length and ISD was also found. This confirms that step length and ISD decrease are clinical manifestations of both gait and speech akinesia, that they are both responsive to levodopa and STN-DBS and that just as akinesia is the main gait deficit, speech akinesia may be the main speech deficit in PD. The negative correlation between walking cadence and SPIR in CS underlines the different strategies used to modulated gait and speech velocity: to walk faster, CS increase the number of steps they make, whereas to speak faster, they decrease the number of speech interpauses and pauses.
This result suggests that the SPIR is a good index to analyse speech rhythmicity, just as the walking cadence is a good index to analyse gait rhythmicity. In PD, a similar phenomenon was observed only under levodopa suggesting that walking cadence and SPIR are regulated by different non dopaminergic structures and that rhythmic perturbations do not always affect speech and gait concurrently, but that they may occur earlier in speech, where a two-fold deficit occurs due to the patients' inability to internally regulate either the number of pauses or the ISD. Table 1 FIGURE CAPTIONS: Step/min Walking Velocity
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